Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Cereb Blood Flow Metab ; 23(2): 232-9, 2003 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-12571454

RESUMO

The authors investigated the effect of the C1 inhibitor (C1-INH), the only known inhibitor of complement C1, in a murine model of transient focal ischemia. Ischemia was induced by intraluminal occlusion of the middle cerebral artery. After 2 hours, reperfusion was produced by removing the nylon monofilament occluding the artery. The effect of 15 U C1-INH (intravenously) was evaluated in terms of general and focal neurologic deficits, ischemic volume, neutral red staining (to identify the brain areas subject to ischemic damage), and glial fibrillary acidic protein immunoreactivity (to show astrocytic response). Forty-eight hours after ischemia, C1-INH significantly improved general and focal deficits by 36% and 54%, respectively, and significantly reduced infarct volume (CI-INH, 6.69% +/- 2.93%; saline, 24.24% +/- 8.24%) of total brain. Neutral red staining further showed the strong protective effect of C1-INH in cortex, hippocampus, and striatum. Astrocyte activation induced by ischemia was not affected by C1-INH. These findings show that C1-INH displayed a potent neuroprotective action by effectively reducing ischemia-reperfusion injury.


Assuntos
Complemento C1/metabolismo , Proteínas Inativadoras do Complemento/farmacologia , Ataque Isquêmico Transitório/patologia , Fármacos Neuroprotetores/farmacologia , Animais , Encéfalo/metabolismo , Encéfalo/patologia , Infarto Cerebral/etiologia , Infarto Cerebral/patologia , Proteína Glial Fibrilar Ácida/metabolismo , Ataque Isquêmico Transitório/complicações , Ataque Isquêmico Transitório/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos , Doenças do Sistema Nervoso/etiologia , Traumatismo por Reperfusão/patologia
2.
Neuroscience ; 114(3): 591-9, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12220562

RESUMO

Sympathetic hyperactivity in rats with heart failure is associated with increased extracellular noradrenaline in the hypothalamic paraventricular nucleus at rest. However, it is unknown how this nucleus responds to stressful stimuli. In the present study we therefore examined the basal and stress-induced release of noradrenaline in the paraventricular nucleus of conscious Sprague-Dawley rats with heart failure measured by in vivo microdialysis. Basal noradrenaline concentration in the paraventricular nucleus of rats with heart failure was more than double that in sham-operated controls. Immobilization stress decreases noradrenaline levels in the paraventricular nucleus of rats with heart failure to 57% of baseline, while it increased in sham-operated controls to 228%. However, serum corticosterone was similarly elevated at 30 and 90 min post-stress in both experimental groups. We have shown that heart failure causes an impairment of the central noradrenergic system's response to acute sympatho-excitation but does not affect the hypothalamo-pituitary-adrenocortical response.


Assuntos
Insuficiência Cardíaca/metabolismo , Microdiálise , Norepinefrina/metabolismo , Estresse Fisiológico/metabolismo , Animais , Corticosterona/sangue , Imobilização/fisiologia , Masculino , Microdiálise/métodos , Microdiálise/estatística & dados numéricos , Núcleo Hipotalâmico Paraventricular/metabolismo , Ratos , Ratos Sprague-Dawley
3.
Brain Res Mol Brain Res ; 61(1-2): 195-202, 1998 Oct 30.
Artigo em Inglês | MEDLINE | ID: mdl-9795215

RESUMO

Cortical Spreading Depression (CSD) is a slowly propagating wave of depolarization and negative interstitial DC potential, that when induced in the rat brain extends across the entire homolateral hemisphere. Despite evidence that CSD does not penetrate into subcortical regions, neurochemical changes in areas anatomically connected to cortex have been reported. In this study in situ hybridization histochemistry was used to examine the levels of cholecystokinin (CCK), proenkephalin (ENK) and prodynorphin (DYN) mRNA in cortex and forebrain basal ganglia following KCl-induced CSD. Unilateral CSD was induced by topical application of 3 M KCl ( approximately 10 microliter) onto the right parietal cortex for 10 min and rats were then killed 1-6 h and 1-28 days later. CCK mRNA levels were increased (P<0.01) in the ipsilateral neocortex 3 h after CSD (13% above levels in contralateral side), reached a peak at 2 days ( approximately 70%) and were still elevated at 7 (30%) but not, 14 or 28 days later. Unilateral CSD also produced a rapid and sustained increase (P<0.05) in ENK mRNA in ipsilateral piriform cortex (from 3 h to 2 days; 70-250% above contralateral), and a delayed increase in caudate putamen and olfactory tubercle at 1 and 2 days ( approximately 25% in both regions), but levels were again equivalent to control at 7 days and beyond. In contrast, no marked changes in neocortical ENK mRNA, or DYN mRNA in both cortex and basal ganglia, were observed under these conditions. These findings demonstrate that CSD has specific, rapid and long-lasting effects on neuropeptide expression in neocortex and subcortical areas. CSD-induced changes in mesostriatal ENK mRNA are proposed to reflect synaptic activation of local neurons via cortical afferent projections.


Assuntos
Córtex Cerebral/metabolismo , Corpo Estriado/metabolismo , Encefalinas/genética , Vias Neurais/fisiologia , Precursores de Proteínas/genética , RNA Mensageiro/biossíntese , Animais , Encéfalo , Córtex Cerebral/química , Córtex Cerebral/efeitos dos fármacos , Colecistocinina/análise , Colecistocinina/genética , Corpo Estriado/química , Corpo Estriado/efeitos dos fármacos , Depressão Química , Encefalinas/análise , Regulação da Expressão Gênica/efeitos dos fármacos , Hibridização In Situ , Masculino , Potenciais da Membrana/efeitos dos fármacos , Vias Neurais/efeitos dos fármacos , Cloreto de Potássio/administração & dosagem , Cloreto de Potássio/farmacologia , Prosencéfalo/química , Prosencéfalo/efeitos dos fármacos , Prosencéfalo/metabolismo , Precursores de Proteínas/análise , RNA Mensageiro/análise , RNA Mensageiro/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa